Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Pacira BioSciences, Inc. (PCRX) had Weighted-Average Shares Outstanding (Diluted) of 46.53M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$168.92M |
|
$4.81M |
|
$34.31M |
|
$134.62M |
|
$166.93M |
|
$1.99M |
|
$6.72M |
|
$8.71M |
|
$8.71M |
|
$4.81M |
|
$4.81M |
|
$4.81M |
|
$4.81M |
|
$1.99M |
|
$24.02M |
|
46.27M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
46.53M |
$0.10 |
|
$0.10 |
|
| Balance Sheet Financials | |
$759.96M |
|
$164.45M |
|
$826.71M |
|
$1.59B |
|
$314.73M |
|
$381.29M |
|
$473.40M |
|
$788.13M |
|
$798.54M |
|
$342.05M |
|
$798.54M |
|
46.28M |
|
| Cash Flow Statement Financials | |
$35.46M |
|
$-25.63M |
|
$-2.99M |
|
$276.77M |
|
$283.61M |
|
$6.84M |
|
$14.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
0.32 |
|
0.73 |
|
79.69% |
|
1.18% |
|
1.18% |
|
-- |
|
5.15% |
|
2.85% |
|
$26.91M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.26 |
|
1.61 |
|
55.81 |
|
0.60% |
|
1.41% |
|
0.30% |
|
0.41% |
|
$17.25 |
|
$0.58 |
|
$0.76 |
|